Rai Neo Pharma on Saturday announced the launch of its operations in Lucknow as part of its expansion strategy focused on Uttar Pradesh and other fast-growing healthcare markets in North and Central India.The pharmaceutical company said it plans to strengthen access to affordable medicines and healthcare delivery in Tier II and Tier III cities, thereby establishing Lucknow as a key hub for its North India operations.The announcement was made during a press conference in Lucknow, where the company outlined its regional growth plans and healthcare strategy.Rai Neo Pharma said it will offer a portfolio of more than 90 formulations, covering both acute and long-term treatments. The portfolio includes medicines for antibiotics, diabetes care, gastro-intestinal disorders, pain and orthopedic treatments, respiratory and allergy care, cardiovascular care and dermatology.The company said it is also developing additional advanced formulations as part of its future pipeline.Founder Amit Patni said Lucknow serves as a major health care and referral center for Uttar Pradesh and neighboring states, with patients from smaller cities and towns relying on the city for specialized treatment.Patni said, “Lucknow is an important healthcare hub not only for Uttar Pradesh, but for a large patient ecosystem across the entire geography. The region is witnessing growing healthcare needs, especially around chronic disease management, affordability and continuity of treatment.”The company said it is expanding its presence in Uttar Pradesh, Bihar, Madhya Pradesh and Delhi-NCR along with other high-growth healthcare markets.Re Neo Pharma said it will work through a mix of in-house capabilities and strategic manufacturing partnerships to scale up operations while maintaining quality and compliance standards.